GE launches temperature controlled processing tech for CAR T-cell therapy – BioPharma-Reporter.com
BioPharma-Reporter.comGE launches temperature controlled processing tech for CAR T-cell therapyBioPharma-Reporter.comThe technology can be applied to any type of cellular therapy, including chimeric antigen receptor (CAR) T-cell therapy. “A new softwar… Continue reading
